Moderna to Present at Upcoming Investor Conferences in March
Cowen and Company39th Annual Health Care Conferencein Bostonon Monday, March 11, 2019at 2:50 p.m. ET. Barclays Global Healthcare Conference2019 in Miamion Thursday, March 14, 2019at 8:30 a.m. ET.
- Oppenheimer 29th Annual Healthcare
New Yorkon Tuesday, March 19, 2019at 8:35 a.m. ET.
A live webcast of each presentation will be available under “Events &
Presentations” in the Investors section of the
Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.
Headquartered in Cambridge, Mass., Moderna currently has strategic
alliances for development programs with